top of page

BackTable / Urology / Contributor

Dr. Daniel Spratt on the BackTable Urology Podcast

Dr. Daniel Spratt

Radiation Oncologist

Dr. Daniel Spratt is the chair of radiation oncology at University Hospitals (UH) Cleveland Medical Center Seidman Cancer Center and a professor with Case Western Reserve University in Cleveland, Ohio.

Listen to Dr. Daniel Spratt on the BackTable Urology Podcast

The BackTable Podcast is a knowledge resource by physicians for physicians. Learn from the experiences and expertise of Dr. Daniel Spratt and get practical advice on how to build your practice by listening to the BackTable Urology Podcast.

Ep 113 Radiotherapy for High Risk Prostate Cancer with Dr. Daniel Spratt
00:00 / 01:04
BackTable CMEfy button

Stay Up To Date

Follow:

Subscribe:

Sign Up:

About Dr. Daniel Spratt

Dr. Daniel Spratt, MD, is a board-certified, international expert in the management of prostate cancer. Dr. Spratt attended Vanderbilt University (Nashville, Tennessee) for his medical training and completed his Radiation Oncology residency at Memorial Sloan Kettering (New York, New York).

He joined the University of Michigan in 2015, where he developed a large NIH-funded translational and clinical research group and was founding co-Director of the Spine Oncology Program. Dr. Spratt received a number of awards in recognition for his teaching, mentorship, research and service during his time at University of Michigan. Furthermore, he was promoted to a tenured full professor faster than any other faculty member at the university, obtaining tenure in just five years following the completion of his training at Memorial Sloan Kettering. He served as the Vice Chair in the Department of Radiation Oncology and Chair of the Genitourinary Clinical Research Team until April 2021, when he joined UH and CWRU.

Dr. Spratt currently serves as chair of the Department of Radiation Oncology at University Hospitals Cleveland Medical Center, and he joined the faculty of Case Western Reserve University School of Medicine in 2021. He also holds the Vincent K. Smith Chair in Radiation Oncology. Dr. Spratt’s clinical expertise encompasses the management of genitourinary cancers (prostate, bladder, kidney, and testicular), metastasis-directed radiotherapy, and spine stereotactic body radiotherapy.

Dr. Spratt is an international expert in the management of prostate cancer and the development and validation of prognostic and predictive biomarkers. His research expertise centers on the development and validation of prognostic and predictive biomarkers used to personalize treatment of cancer patients while avoiding over- and under-treatment. Dr. Spratt has received federal funding from the NIH, Department of Defense, and numerous foundations for his research. He is the principal or co-principal investigator on over 10 institutional, national or multinational clinical trials, runs a National Institute of Health-funded translational lab, and has mentored over 40 students and faculty.

Dr. Spratt has published over 300 peer-reviewed manuscripts, including practice-changing work in the New England Journal of Medicine, JAMA, Lancet Oncology, JAMA Oncology and the Journal of Clinical Oncology. He serves as the Chair for NRG Oncology's Intact Prostate Cancer Subcommittee, and for the National Cancer Institute's Genitourinary Steering Committee. Dr. Spratt regularly receives invitations from all over the world to give lectures on the management and personalization of prostate cancer. Dr. Spratt’s primary professional goal is to create a world-class Department of Radiation Oncology that provides cutting edge personalized and compassionate care.

Learn more by visiting Dr. Daniel Spratt's practice:

Podcasts Featuring Dr. Daniel Spratt

Episode #113

Urology

This week on the BackTable Urology Podcast, Dr. Bagrodia talks with Dr. Daniel Spratt, professor and chairman of radiation oncology at Case Western University in Cleveland, about the workup and treatment of high risk prostate cancer.

Articles Featuring Dr. Daniel Spratt

High-Risk Prostate Cancer: Diagnosis & Treatment Strategies

Radical therapy remains the cornerstone in the treatment of high-risk prostate cancer, encompassing modalities such as radical prostatectomy and brachytherapy. Criteria for the high-risk prostate cancer designation typically include a Gleason score ranging from 8 to 10, grade 4 or 5, or PSA levels surpassing 20.

Radiation Therapy for High-Risk Prostate Cancer: Which Modality is Best?

Urologic oncologist Dr. Aditya Bagrodia and radiation oncologist Dr. Daniel Spratt explain their approach to radiation therapy in high-risk prostate cancer treatment, emphasizing the latest clinical evidence.

Get Connected

Thank you for listening! If you have a question for Dr. Daniel Spratt about a topic discussed on the BackTable Urology Podcast, you can get in touch with this form. Please note that our contributors are not able to respond to every inquiry.

Select which show(s) you would like to subscribe to:

Thanks! Message sent.

Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

backtable-earn-free-cme.jpg
backtable-plus-vi-cta.jpg

Podcasts

Radiotherapy for High Risk Prostate Cancer with Dr. Daniel Spratt on the BackTable Urology Podcast)
Perfecting Rectal Spacer Placement for Optimal Care with Dr. Neil Taunk on the BackTable Urology Podcast)

Topics

Prostate Cancer Condition Overview
Radiation Therapy Procedure Prep

More Contributors

Dr. Neeraj Agarwal on the BackTable Urology Podcast

Dr. Neeraj Agarwal

Dr. David Albala on the BackTable Urology Podcast

Dr. David Albala

Dr. Matthew Allaway on the BackTable Urology Podcast

Dr. Matthew Allaway

Dr. Matthew Allaway on the BackTable Urology Podcast

Dr. Matthew Allaway

Dr. Aditya Bagrodia on the BackTable Urology Podcast

Dr. Aditya Bagrodia

Dr. Bud Burnett on the BackTable Urology Podcast

Dr. Bud Burnett

bottom of page